Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
IL33 (MIM 608678) is a member of the IL1 (see MIM 147760) family that potently drives production of T helper-2 (Th2)-associated cytokines (e.g., IL4; MIM 147780). Additionally we are shipping Interleukin 33 Proteins (110) and Interleukin 33 Kits (78) and many more products for this protein.
Showing 10 out of 364 products:
Mouse (Murine) Polyclonal Interleukin 33 Primary Antibody for FACS - ABIN2661329
Arend, Palmer, Gabay: IL-1, IL-18, and IL-33 families of cytokines. in Immunological reviews 2008
Show all 5 references for ABIN2661329
Human Polyclonal Interleukin 33 Primary Antibody for EIA, WB - ABIN500014
Dinarello: Interleukin-18, a proinflammatory cytokine. in European cytokine network 2000
Show all 4 references for ABIN500014
Human Polyclonal Interleukin 33 Primary Antibody for EIA, IF - ABIN500012
Brint, Xu, Liu, Dunne, McKenzie, ONeill, Liew: ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. in Nature immunology 2004
Show all 4 references for ABIN500012
Human Monoclonal Interleukin 33 Primary Antibody for Func, IP - ABIN1169172
Pace, Di Sano, Sciarrino, Scafidi, Ferraro, Chiappara, Siena, Gangemi, Vitulo, Giarratano, Gjomarkaj: Cigarette smoke alters IL-33 expression and release in airway epithelial cells. in Biochimica et biophysica acta 2014
Show all 4 references for ABIN1169172
Human Polyclonal Interleukin 33 Primary Antibody for EIA, WB - ABIN401104
Hayakawa, Hayakawa, Matsuyama, Tamemoto, Okazaki, Tominaga: Mature interleukin-33 is produced by calpain-mediated cleavage in vivo. in Biochemical and biophysical research communications 2009
Show all 4 references for ABIN401104
Human Polyclonal Interleukin 33 Primary Antibody for FACS, IHC - ABIN2665497
McLaren, Michael, Salter, Ashlin, Calder, Miller, Liew, Ramji: IL-33 reduces macrophage foam cell formation. in Journal of immunology (Baltimore, Md. : 1950) 2010
Show all 3 references for ABIN2665497
Human Polyclonal Interleukin 33 Primary Antibody for FACS - ABIN2661328
Onda, Kasuya, Takakura, Hori, Imaizumi, Takeuchi, Inoue, Takeda: Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1999
Show all 3 references for ABIN2661328
Human Polyclonal Interleukin 33 Primary Antibody for IHC, WB - ABIN2784443
Humphreys, Xu, Hepworth, Liew, Grencis: IL-33, a potent inducer of adaptive immunity to intestinal nematodes. in Journal of immunology (Baltimore, Md. : 1950) 2008
Human Monoclonal Interleukin 33 Primary Antibody for EIA, WB - ABIN317536
Baekkevold, Roussigné, Yamanaka, Johansen, Jahnsen, Amalric, Brandtzaeg, Erard, Haraldsen, Girard: Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. in The American journal of pathology 2003
IL-33-ERK (show EPHB2 Antibodies)/JNK (show MAPK8 Antibodies)/p38 (show CRK Antibodies)/Egr-1 (show EGR1 Antibodies)/TSLP (show TSLP Antibodies) axis involved in allergic skin Th2 inflammation
data suggest that IL-33/ST2 (show SULT2A1 Antibodies) axis closely associates with poor prognosis of EOC patients, and it promotes ovarian cancer growth and metastasis through regulating ERK (show EPHB2 Antibodies) and JNK (show MAPK8 Antibodies) signaling pathways
Our findings indicate that the alarmin cytokines IL-33 and IL-25 (show IL25 Antibodies) increase basophil activation and migratory potential, and may pose as a novel therapeutic targets for the treatment of allergic asthma.
Targeting IL-33 was a promising strategy for controlling autoantibody production in AIHA patients
Data suggest that increased plasma Interleukin-33 (IL-33) levels in patients with rheumatoid arthritis (RA) could be a possible biomarker to reflect the potential risks of bone erosion.
IL13 (show IL13 Antibodies) gene transcription can be directly activated by nuclear IL-33, which is negatively regulated by the deubiquitinase USP17.
IL-33(+) Muller cells were more abundant and IL-33 cytokine was elevated in advanced age-related macular degeneration cases compared with age-matched controls.
Results indicate that IL-33 may reversibly destabilize the endothelial barrier, thus accelerating the supply with immunomodulators and assisting leukocytes to reach wounded tissue.
No significant association between IL33 rs7025417, IL33 rs7044343, IL1RL1 (show IL1RL1 Antibodies) rs2058660, IL1RL1 (show IL1RL1 Antibodies) rs2310173 and IL1RL1 (show IL1RL1 Antibodies) rs13015714 and cIMT values was observed.
Decreased expression of IL-33 in immune thrombocytopenia
pre-treatment with the ERK1/2 (show MAPK1/3 Antibodies) inhibitor U0126 or anti-IL-33 antibody significantly abolished the ovalbumin (show OVA Antibodies)-induced airway remodeling, increased expressions of IL-33
IL-33 promotes degranulation of bone marrow-derived mast cells and release of cytokines IL-1beta (show IL1B Antibodies), IL-6 (show IL6 Antibodies) and TNF-alpha (show TNF Antibodies).
pulmonary interstitial macrophages may not be a source of IL-33 during Respiratory syncytial virus infection
demonstrate a pathogenic role for IL-33-mediated eosinophilia and activation of Th2 immunity in chronic intestinal inflammation
IL-33 as a novel regulator of neutrophil function in antibacterial infection
Our results provide novel insights into the mechanism of action behind alum-induced cytokine responses and show that IL-33 is sufficient to provide a robust secondary antibody response independently of alum.
Results demonstrated that IL-33 was released by activated astrocytes actively, and by damaged neurons during experimental autoimmune encephalomyelitis
This study indicates a pathogenic role of alarmin IL-33 in a murine model of scrub typhus and highlights infection-triggered endothelial cell damage and IL-33-mediated pathological changes during the course of Orientia infection.
IL-33, an alarmin released in response to tissue damage, was secreted from vaginal epithelium after the depletion of commensal microbiota.
promotes muscle T reg (show KCNH2 Antibodies) homeostasis in young mice, and efficient regeneration of injured muscles in aged mice
IL-33 may be a key molecule operating in eosinophil-mediated fibrosis in high-dose-per fraction irradiated skin.
IL33 (MIM 608678) is a member of the IL1 (see MIM 147760) family that potently drives production of T helper-2 (Th2)-associated cytokines (e.g., IL4\; MIM 147780). IL33 is a ligand for IL33R (IL1RL1\; MIM 601203), an IL1 family receptor that is selectively expressed on Th2 cells and mast cells (summary by Yagami et al., 2010
, DVS27-related protein
, interleukin-1 family member 11
, nuclear factor for high endothelial venules
, nuclear factor from high endothelial venules